Dementia researchers will be able to tap into investment of £1.9 million for work on identifying the earliest brain changes linked with conditions such as Alzheimer’s disease.
Eight medicines have taken a big leap towards being approved in Europe having won the support of the European Medicines Agency’s Committee for Medicinal Products for Human Use.